1-8 of 8
Per Eystein Lønning
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNA Methylation Status of Key Cell-Cycle Regulators Such as CDKNA2/p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil in Locally Advanced Breast Tumors

Jovana Klajic, Florence Busato, Hege Edvardsen, Nizar Touleimat, Thomas Fleischer, Ida Bukholm, Anne-Lise Børresen-Dale, Per Eystein Lønning, Jörg Tost, Vessela N. Kristensen
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (24): 6357–6366.
https://doi.org/10.1158/1078-0432.CCR-14-0297
Published: 14 December 2014
View articletitled, DNA Methylation Status of Key Cell-Cycle Regulators Such as CDKNA2/p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil in Locally Advanced Breast Tumors
Open the PDF for DNA Methylation Status of Key Cell-Cycle Regulators Such as CDKNA2/p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil in Locally Advanced Breast Tumors in another window
Includes: Supplementary data
Journal Articles

Gene Expression Profiling–Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome

Göran Jönsson, Christian Busch, Stian Knappskog, Jürgen Geisler, Hrvoje Miletic, Markus Ringnér, Johan R. Lillehaug, Åke Borg, Per Eystein Lønning
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (13): 3356–3367.
https://doi.org/10.1158/1078-0432.CCR-09-2509
Published: 30 June 2010
View articletitled, Gene Expression Profiling–Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome
Open the PDF for Gene Expression Profiling–Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome in another window
Includes: Supplementary data
Journal Articles

The Novel p21 Polymorphism p21G251A Is Associated with Locally Advanced Breast Cancer

Vidar Staalesen, Stian Knappskog, Ranjan Chrisanthar, Silje H. Nordgard, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Inger Torhild Gram, Vessela N. Kristensen, Anne-Lise Børresen-Dale, Johan Richard Lillehaug, Per Eystein Lønning
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6000–6004.
https://doi.org/10.1158/1078-0432.CCR-05-2822
Published: 24 October 2006
View articletitled, The Novel p21 Polymorphism p21G251A Is Associated with Locally Advanced Breast Cancer
Open the PDF for The Novel p21 Polymorphism p21G251A Is Associated with Locally Advanced Breast Cancer in another window
Journal Articles

Interaction between p53 Staining and High-Dose Chemotherapy in Breast Cancer

Per Eystein Lønning, Anne-Lise Børresen-Dale
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 2289.
https://doi.org/10.1158/1078-0432.CCR-06-0129
Published: 11 April 2006
View articletitled, Interaction between p53 Staining and High-Dose Chemotherapy in Breast Cancer
Open the PDF for Interaction between p53 Staining and High-Dose Chemotherapy in Breast Cancer in another window
Journal Articles

Aromatase Inhibition: Translation into a Successful Therapeutic Approach

Jürgen Geisler, Per Eystein Lønning
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (8): 2809–2821.
https://doi.org/10.1158/1078-0432.CCR-04-2187
Published: 18 April 2005
View articletitled, Aromatase Inhibition: Translation into a Successful Therapeutic Approach
Open the PDF for Aromatase Inhibition: Translation into a Successful Therapeutic Approach in another window
Journal Articles

Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer

Vidar Staalesen, Beryl Leirvaag, Johan Richard Lillehaug, Per Eystein Lønning
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (10): 3438–3443.
https://doi.org/10.1158/1078-0432.CCR-03-0796
Published: 24 May 2004
View articletitled, Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer
Open the PDF for Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer in another window
Journal Articles

TP53 Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer

Stephanie Geisler, Anne-Lise Børresen-Dale, Hilde Johnsen, Turid Aas, Jürgen Geisler, Lars Andreas Akslen, Gun Anker, Per Eystein Lønning
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (15): 5582–5588.
Published: 03 December 2003
View articletitled, TP53 Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer
Open the PDF for TP53 Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer in another window
Journal Articles

Influence of Neoadjuvant Anastrozole (Arimidex) on Intratumoral Estrogen Levels and Proliferation Markers in Patients with Locally Advanced Breast Cancer

Jürgen Geisler, Simone Detre, Hildegunn Berntsen, Lars Ottestad, Bernt Lindtjørn, Mitch Dowsett, Per Eystein Lønning
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (5): 1230–1236.
Published: 01 May 2001
View articletitled, Influence of Neoadjuvant Anastrozole (Arimidex) on Intratumoral Estrogen Levels and Proliferation Markers in Patients with Locally Advanced Breast Cancer
Open the PDF for Influence of Neoadjuvant Anastrozole (Arimidex) on Intratumoral Estrogen Levels and Proliferation Markers in Patients with Locally Advanced Breast Cancer in another window